Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on January 24, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print January 24, 2008, doi: 10.1161/ATVBAHA.107.159913
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/4/771    most recent
ATVBAHA.107.159913v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Teichert, M.
Right arrow Articles by Stricker, B. H.Ch.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teichert, M.
Right arrow Articles by Stricker, B. H.Ch.

Submitted on September 18, 2007
Accepted on January 6, 2008

Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism and Aortic Calcification. The Rotterdam Study

M. Teichert ; L. E. Visser ; R. H.N. van Schaik ; A. Hofman ; A. G. Uitterlinden ; P. A.G.M. De Smet ; J. C.M. Witteman ; and B. H.Ch. Stricker *

From the Department of Epidemiology & Biostatistics (M.T., L.E.V., A.H., A.G.U., J.C.M.W., B.H.C.S.), Erasmus Medical Center, Rotterdam; the Scientific Institute Dutch Pharmacists (M.T., P.A.G.M.D.S.), The Hague; the Department of Hospital Pharmacy (L.E.V.), Erasmus Medical Center, Rotterdam; the Department of Clinical Chemistry (R.H.N.v.S., A.G.U.), Erasmus Medical Center, Rotterdam; the Department of Internal Medicine (A.g.U., B.H.C.S.), Erasmus Medical Center, Rotterdam; and the Drug Safety Unit (B.H.C.S.), Inspectorate for Health Care, The Hague, The Netherlands.

* To whom correspondence should be addressed. E-mail: b.stricker{at}erasmusmc.nl.

Objective—Besides effects on hemostasis, vitamin K-dependent proteins play a role in bone mineralization and arterial calcification. We investigated the association between the VKORC1 1173C>T polymorphism and calcification of the aortic far wall in a large population-based cohort.

Methods and Results—Aortic calcification was diagnosed by radiographic detection of calcified deposits in the abdominal aorta. In all cohort members for whom DNA was available, the C1173T SNP of VKORC1 (rs9934438) was determined. With multivariable logistic regression analysis the association between this polymorphism and the risk of aortic calcification was calculated, adjusted for potential confounders. The T allele frequency of the VKORC1 1173C>T polymorphism was 38.8%. 1185 (37.2%) persons were homozygous CC, 1529 (48,0%) were heterozygous CT and 473 (14.8%) were homozygous TT. Persons with at least one T-allele had a statistically significant 19% (95% CI 2 to 40%) risk increase of calcification of the aortic far wall compared to CC homozygous persons, adjusted for age and gender.

Conclusion—The T-allele of the VKORC1 1173C>T polymorphism was associated with a significantly higher risk of aortic calcification in Whites.


Key words: aortic calcification • matrix Gla protein • vitamin K cycle • VKORC1 polymorphism